toggle visibility Search & Display Options

Select All    Deselect All
 |   | 

Deprecated: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in /home/acutrialsocom/public_html/refbase-ocom/includes/ on line 5275
  Record Links
Author (up) Wang, S.; Yang, H.; Zhang, J.; Zhang, B.; Liu, T.; Gan, L.; Zheng, J. url  doi
  Title Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial Type of Study Journal Article
  Year 2016 Publication BMC Complementary and Alternative Medicine Abbreviated Journal BMC Complement Altern Med  
  Volume 16 Issue Pages 361  
  Keywords Acupuncture; Cerebral infarction; Mild cognitive impairment; Montreal Cognitive Assessment scale; Nimodipine  
  Abstract BACKGROUND: Cerebral infarction frequently leads to mild cognitive impairment (MCI). Prompt management of MCI can prevent vascular dementia and improve patient outcome. This single center randomized controlled trial aims to investigate the efficacy and safety of acupuncture and nimodipine to treat post-cerebral infarction MCI. METHODS: A total of 126 Chinese patients with post-cerebral infarction MCI recruited from the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine between April 2013 and June 2014 were randomized at 1:1: 1 ratio into nimodipine alone (30 mg/time and 3 times daily), acupuncture alone (30 min/time, 6 times/week), and nimodipine + acupuncture groups. The treatments were 3 months. Cognitive function was evaluated using Montreal Cognitive Assessment (MoCA) scale at enrollment interview, at the end of 3-month therapy, and at the post-treatment 3-month follow-up. RESULTS: The per-protocol set included 39, 40, and 40 patients from nimodipine alone, acupuncture alone, and the combination group, respectively, was analyzed. Intra-group comparison revealed that MoCA score at the follow-up improved significantly by 15.8 +/- 10.9, 20.9 +/- 13.8 %, and 30.2 +/- 19.7 % compared with the baseline MoCA for nimodipine alone, acupuncture alone, and the combination group, respectively. Inter-group comparison demonstrated that the combination therapy improved MoCA score (5.5 +/- 2.2) at significantly higher extent than nimodipine alone (3.1 +/- 1.8) and acupuncture alone (4.3 +/- 2.3) at the follow-up (All P < 0.05), and significantly higher proportion of patients in acupuncture alone group (80 %) and the combination therapy group (90 %) than in nimodipine alone group (56.4 %) showed >/=12 % MoCA score improvement compared with the baseline MoCA (All P < 0.05). No adverse event was reported during the study. CONCLUSION: Acupuncture may be used as an additional therapy to conventional pharmacological treatment to further improve the clinical outcomes of patients with post-cerebral infarction MCI. TRIAL REGISTRATION: The study was registered at the Chinese Clinical Trial Registry ( , Unique Identifier: ChiCTR-IOR-15007366 ). The date of registration is November 4, 2015.  
  Address Department of Acupuncture, The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.  
  Language English Number of Treatments  
  Treatment Follow-up Frequency Number of Participants  
  Time in Treatment Condition
  Disease Category OCSI Score  
  Notes PMID:27623621; PMCID:PMC5022140 Approved no  
  Call Number OCOM @ refbase @ Serial 2155  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: